JP2023518376A5 - - Google Patents
Info
- Publication number
- JP2023518376A5 JP2023518376A5 JP2022555836A JP2022555836A JP2023518376A5 JP 2023518376 A5 JP2023518376 A5 JP 2023518376A5 JP 2022555836 A JP2022555836 A JP 2022555836A JP 2022555836 A JP2022555836 A JP 2022555836A JP 2023518376 A5 JP2023518376 A5 JP 2023518376A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- seq
- peptide
- use according
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2020900807A AU2020900807A0 (en) | 2020-03-16 | Compositions for treating respiratory tract infection and uses thereof | |
| AU2020900807 | 2020-03-16 | ||
| AU2020900818 | 2020-03-17 | ||
| AU2020900818A AU2020900818A0 (en) | 2020-03-17 | Compositions for treating respiratory tract infection and uses thereof | |
| AU2020904226 | 2020-11-16 | ||
| AU2020904226A AU2020904226A0 (en) | 2020-11-16 | Compositions for treating respiratory tract infection and uses thereof | |
| PCT/AU2021/050229 WO2021184062A1 (en) | 2020-03-16 | 2021-03-16 | Compositions for treating respiratory tract infection and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023518376A JP2023518376A (ja) | 2023-05-01 |
| JP2023518376A5 true JP2023518376A5 (enExample) | 2024-03-27 |
Family
ID=77767913
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022555836A Withdrawn JP2023518376A (ja) | 2020-03-16 | 2021-03-16 | 気道感染症を治療するための組成物およびそれらの使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230256059A1 (enExample) |
| EP (1) | EP4121084A4 (enExample) |
| JP (1) | JP2023518376A (enExample) |
| CN (1) | CN115297882A (enExample) |
| AU (1) | AU2021237981A1 (enExample) |
| CA (1) | CA3171917A1 (enExample) |
| WO (1) | WO2021184062A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3996737A4 (en) * | 2019-07-09 | 2023-06-14 | Lateral Ip Pty Ltd | PEPTIDES AND THEIR USES |
| EP4346867A1 (en) * | 2021-05-07 | 2024-04-10 | Lateral Pharma Pty Ltd | Compositions for treating inflammatory airway disease and uses thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI20080333A0 (fi) * | 2008-05-02 | 2008-05-02 | Glykos Finland Oy | Influenssaviruksen nukleiinihappoja ja peptidejä |
| CA2857686C (en) * | 2011-12-09 | 2023-01-17 | Metabolic Pharmaceuticals Pty Ltd | Use of growth hormone fragments |
| US9139626B2 (en) * | 2012-09-13 | 2015-09-22 | The Mitre Corporation | Mitrecin A polypeptide with antimicrobial activity |
| CN112218650A (zh) * | 2018-01-15 | 2021-01-12 | 单侧Ip私人有限公司 | 肽及其用途 |
| JP7751583B2 (ja) * | 2019-12-27 | 2025-10-08 | ラテラル、アイピー、プロプライエタリー、リミテッド | 環状ペプチド受容体ランチオニンシンテターゼｃ様タンパク質（ｌａｎｃｌ）及びその使用 |
-
2021
- 2021-03-16 CA CA3171917A patent/CA3171917A1/en active Pending
- 2021-03-16 WO PCT/AU2021/050229 patent/WO2021184062A1/en not_active Ceased
- 2021-03-16 CN CN202180021765.1A patent/CN115297882A/zh active Pending
- 2021-03-16 JP JP2022555836A patent/JP2023518376A/ja not_active Withdrawn
- 2021-03-16 US US17/911,972 patent/US20230256059A1/en active Pending
- 2021-03-16 AU AU2021237981A patent/AU2021237981A1/en not_active Abandoned
- 2021-03-16 EP EP21770411.3A patent/EP4121084A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004505046A5 (enExample) | ||
| CN102325532B (zh) | 用于减轻肺部炎症的左氧氟沙星吸入剂 | |
| JP2023518376A5 (enExample) | ||
| JP2023520323A5 (enExample) | ||
| JP2014518268A5 (enExample) | ||
| JP2008538115A5 (enExample) | ||
| JP2009535352A5 (enExample) | ||
| BR0015908A (pt) | Emprego de compostos org nicos no tratamento de doenças | |
| JP2012500091A5 (enExample) | ||
| CN113304166A (zh) | 核苷类化合物在治疗冠状病毒感染性疾病中的用途 | |
| FI3710036T3 (fi) | Stabiileja askorbiinihappokoostumuksia ja menetelmiä niiden käyttämiseksi | |
| JP2010508365A5 (enExample) | ||
| JP2022537178A5 (enExample) | ||
| JP2010285436A5 (enExample) | ||
| JP2022534776A5 (enExample) | ||
| JP2024504225A5 (enExample) | ||
| JP2020516689A5 (enExample) | ||
| JP2025508656A5 (enExample) | ||
| RU2015129076A (ru) | Арилалкил- и арилоксиалкил-замещенные соединения, блокирующие эпителиальный натриевый канал | |
| JP2023509462A5 (enExample) | ||
| JP2023523557A5 (enExample) | ||
| JP2023536269A5 (enExample) | ||
| JP2023524064A5 (enExample) | ||
| JP2008502699A5 (enExample) | ||
| JP2023524064A (ja) | ウイルス感染を治療又は予防するためのクロファジミン組成物及び方法 |